Physician profile
Yaser Slayyeh
NPI 1932174612
$8,509.85
in general payments reported to CMS, 2019-2025
33 companies · $2,128 in 2025
The $2,128 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $767 · 2021: $1,277 · 2022: $1,355 · 2023: $1,455 · 2024: $716 · 2025: $2,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,436 · Long Term Medical Supply Or Device Loan: $773 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,435.56 |
| Long Term Medical Supply Or Device Loan | $773.33 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $869.87 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $792.82 | 2019-2025 | |
| Angiodynamics, INC. | $773.33 | 2025 | Venacure 1470 Pro |
| Abiomed | $702.49 | 2020-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $635.91 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $599.53 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $496.80 | 2019-2022 | |
| Boston Scientific Corporation | $368.82 | 2020-2025 | Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor, Synergy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.15 | 2019-2025 | Jardiance |
| Pfizer INC. | $331.76 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $323.74 | 2021-2024 | Venclose Maven Catheter |
| Abbott Laboratories | $314.54 | 2020-2024 | Diamondback Peripheral, Diamondback Coronary, Coroflow |
| Merck Sharp & Dohme LLC | $285.30 | 2021-2025 | Verquvo |
| Shockwave Medical, INC | $267.94 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $179.14 | 2021-2025 | Eliquis, Camzyos |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $160.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $156.38 | 2020-2024 | |
| United Therapeutics Corporation | $132.18 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $128.06 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.70 | 2022-2025 | |
| Chiesi USA, INC. | $85.80 | 2020-2021 | |
| Venclose INC. | $72.09 | 2020 | |
| Inari Medical, INC. | $64.52 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $52.88 | 2019-2021 | |
| Cardiva Medical, INC. | $51.41 | 2025 | Optowire |
| Edwards Lifesciences Corporation | $50.12 | 2020-2024 | Pascal |
| Imperative Care, INC | $46.10 | 2025 | Symphony Catheter |
| Becton, Dickinson and Company | $36.62 | 2023-2024 | Venclose Maven Catheter, Lutonix Drug Coated Balloon |
| Amgen INC. | $27.68 | 2024 | Repatha |
| Masimo Corporation | $18.75 | 2023 | Na |
| Cardinal Health 200 LLC | $17.41 | 2020 | |
| Glaxosmithkline, LLC. | $16.52 | 2025 | Shingrix, Arexvy |
| Arbor Pharmaceuticals, INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaser Slayyeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.